

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 7.09238431 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 6.31908663 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 5.51085505 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 5.51085505 |
| 5 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.09324339 |
| 6 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.09324339 |
| 7 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.99508971 |
| 8 | angiotensin maturation (GO:0002003) | 4.94693467 |
| 9 | flavonoid metabolic process (GO:0009812) | 4.42234025 |
| 10 | peptide hormone processing (GO:0016486) | 4.30381408 |
| 11 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.01960267 |
| 12 | protein retention in ER lumen (GO:0006621) | 3.99156157 |
| 13 | COPII vesicle coating (GO:0048208) | 3.93040414 |
| 14 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.90028819 |
| 15 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.86948642 |
| 16 | drug catabolic process (GO:0042737) | 3.84551027 |
| 17 | digestive system process (GO:0022600) | 3.84430610 |
| 18 | endocrine pancreas development (GO:0031018) | 3.78509436 |
| 19 | intestinal epithelial cell development (GO:0060576) | 3.72311659 |
| 20 | digestion (GO:0007586) | 3.69590182 |
| 21 | modified amino acid transport (GO:0072337) | 3.69067701 |
| 22 | signal peptide processing (GO:0006465) | 3.66108901 |
| 23 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.59987261 |
| 24 | positive regulation of mitochondrial fission (GO:0090141) | 3.57144087 |
| 25 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.55454281 |
| 26 | hormone catabolic process (GO:0042447) | 3.52246342 |
| 27 | NADH metabolic process (GO:0006734) | 3.49357243 |
| 28 | synaptic vesicle maturation (GO:0016188) | 3.48067311 |
| 29 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.40237669 |
| 30 | nucleobase catabolic process (GO:0046113) | 3.40036066 |
| 31 | GDP-mannose metabolic process (GO:0019673) | 3.39033829 |
| 32 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.38031978 |
| 33 | glandular epithelial cell differentiation (GO:0002067) | 3.37533424 |
| 34 | regulation of mitochondrial translation (GO:0070129) | 3.36467254 |
| 35 | peptide catabolic process (GO:0043171) | 3.36157467 |
| 36 | glucuronate metabolic process (GO:0019585) | 3.35847545 |
| 37 | uronic acid metabolic process (GO:0006063) | 3.35847545 |
| 38 | cysteine metabolic process (GO:0006534) | 3.35480397 |
| 39 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.34744501 |
| 40 | cellular glucuronidation (GO:0052695) | 3.34380947 |
| 41 | sulfur amino acid catabolic process (GO:0000098) | 3.33672880 |
| 42 | negative regulation of digestive system process (GO:0060457) | 3.33200043 |
| 43 | nucleotide-sugar metabolic process (GO:0009225) | 3.30475025 |
| 44 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.27343565 |
| 45 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.23852531 |
| 46 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.23852531 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 3.22921062 |
| 48 | drug transport (GO:0015893) | 3.21831352 |
| 49 | drug transmembrane transport (GO:0006855) | 3.20855336 |
| 50 | protein localization to cilium (GO:0061512) | 3.17300759 |
| 51 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.16751760 |
| 52 | bile acid and bile salt transport (GO:0015721) | 3.15688899 |
| 53 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.15534851 |
| 54 | sulfate transmembrane transport (GO:1902358) | 3.14491956 |
| 55 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.14451090 |
| 56 | establishment of mitochondrion localization (GO:0051654) | 3.12996342 |
| 57 | xenobiotic catabolic process (GO:0042178) | 3.12211400 |
| 58 | sulfation (GO:0051923) | 3.08805763 |
| 59 | membrane budding (GO:0006900) | 3.06743914 |
| 60 | O-glycan processing (GO:0016266) | 3.04137571 |
| 61 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.03940658 |
| 62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.03524648 |
| 63 | glutamate secretion (GO:0014047) | 3.02904794 |
| 64 | ribonucleoprotein complex disassembly (GO:0032988) | 3.01740414 |
| 65 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.96462512 |
| 66 | folic acid transport (GO:0015884) | 2.95213112 |
| 67 | sulfur compound transport (GO:0072348) | 2.94951856 |
| 68 | thyroid hormone metabolic process (GO:0042403) | 2.93011103 |
| 69 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.91724495 |
| 70 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.91195409 |
| 71 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.91195409 |
| 72 | protein deneddylation (GO:0000338) | 2.90454029 |
| 73 | vitamin A metabolic process (GO:0006776) | 2.90006441 |
| 74 | transcytosis (GO:0045056) | 2.89929683 |
| 75 | cullin deneddylation (GO:0010388) | 2.89191513 |
| 76 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.87180432 |
| 77 | respiratory electron transport chain (GO:0022904) | 2.84133861 |
| 78 | daunorubicin metabolic process (GO:0044597) | 2.83079534 |
| 79 | polyketide metabolic process (GO:0030638) | 2.83079534 |
| 80 | doxorubicin metabolic process (GO:0044598) | 2.83079534 |
| 81 | proteasome assembly (GO:0043248) | 2.82878868 |
| 82 | ubiquinone metabolic process (GO:0006743) | 2.82798388 |
| 83 | peptide metabolic process (GO:0006518) | 2.81395665 |
| 84 | regulation of cholesterol esterification (GO:0010872) | 2.80662798 |
| 85 | L-methionine biosynthetic process (GO:0071265) | 2.80352355 |
| 86 | amino acid salvage (GO:0043102) | 2.80352355 |
| 87 | L-methionine salvage (GO:0071267) | 2.80352355 |
| 88 | electron transport chain (GO:0022900) | 2.80043453 |
| 89 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.79657002 |
| 90 | ATP synthesis coupled proton transport (GO:0015986) | 2.79657002 |
| 91 | actin filament depolymerization (GO:0030042) | 2.79641184 |
| 92 | vitamin transport (GO:0051180) | 2.79249522 |
| 93 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.78407851 |
| 94 | chaperone-mediated protein transport (GO:0072321) | 2.77764462 |
| 95 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.77258663 |
| 96 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.77258663 |
| 97 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.77258663 |
| 98 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.76788140 |
| 99 | gamma-aminobutyric acid transport (GO:0015812) | 2.75968703 |
| 100 | nucleotide transmembrane transport (GO:1901679) | 2.75007648 |
| 101 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.73666523 |
| 102 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.73507353 |
| 103 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.73507353 |
| 104 | ubiquinone biosynthetic process (GO:0006744) | 2.73385984 |
| 105 | mitochondrial calcium ion transport (GO:0006851) | 2.72542579 |
| 106 | fatty acid beta-oxidation (GO:0006635) | 2.72479418 |
| 107 | protein-cofactor linkage (GO:0018065) | 2.72220294 |
| 108 | quinone biosynthetic process (GO:1901663) | 2.69598994 |
| 109 | protein localization to synapse (GO:0035418) | 2.69012033 |
| 110 | regulation of cholesterol metabolic process (GO:0090181) | 2.68411594 |
| 111 | renal absorption (GO:0070293) | 2.68297051 |
| 112 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.67848716 |
| 113 | mitochondrion transport along microtubule (GO:0047497) | 2.67848716 |
| 114 | fatty acid oxidation (GO:0019395) | 2.67679952 |
| 115 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.67468428 |
| 116 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.67468428 |
| 117 | neurotransmitter secretion (GO:0007269) | 2.65828929 |
| 118 | phenylpropanoid metabolic process (GO:0009698) | 2.65634103 |
| 119 | glutathione derivative biosynthetic process (GO:1901687) | 2.65022464 |
| 120 | glutathione derivative metabolic process (GO:1901685) | 2.65022464 |
| 121 | sulfate transport (GO:0008272) | 2.64634120 |
| 122 | lysine metabolic process (GO:0006553) | 2.64309216 |
| 123 | lysine catabolic process (GO:0006554) | 2.64309216 |
| 124 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.64215173 |
| 125 | tricarboxylic acid cycle (GO:0006099) | 2.63274749 |
| 126 | organelle disassembly (GO:1903008) | 2.63166692 |
| 127 | phospholipid efflux (GO:0033700) | 2.62531694 |
| 128 | quinone metabolic process (GO:1901661) | 2.62313835 |
| 129 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.60858364 |
| 130 | lipid oxidation (GO:0034440) | 2.60675088 |
| 131 | exogenous drug catabolic process (GO:0042738) | 2.60391988 |
| 132 | tricarboxylic acid metabolic process (GO:0072350) | 2.59768742 |
| 133 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.58603312 |
| 134 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.58301551 |
| 135 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.58073590 |
| 136 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.57636991 |
| 137 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.57538122 |
| 138 | protein autoprocessing (GO:0016540) | 2.57335013 |
| 139 | fructose metabolic process (GO:0006000) | 2.56919630 |
| 140 | fatty acid catabolic process (GO:0009062) | 2.56575263 |
| 141 | ER overload response (GO:0006983) | 2.54262793 |
| 142 | behavioral response to nicotine (GO:0035095) | 2.54146943 |
| 143 | drug metabolic process (GO:0017144) | 2.54095350 |
| 144 | alkaloid metabolic process (GO:0009820) | 2.53855694 |
| 145 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.53730433 |
| 146 | regulation of triglyceride catabolic process (GO:0010896) | 2.53198927 |
| 147 | synaptic vesicle exocytosis (GO:0016079) | 2.53044104 |
| 148 | hepatocyte apoptotic process (GO:0097284) | 2.52698786 |
| 149 | protein maturation by protein folding (GO:0022417) | 2.50721627 |
| 150 | peptidyl-histidine modification (GO:0018202) | 2.50687536 |
| 151 | succinate metabolic process (GO:0006105) | 2.49973505 |
| 152 | regulation of guanylate cyclase activity (GO:0031282) | 2.49509402 |
| 153 | epithelial structure maintenance (GO:0010669) | 2.49169445 |
| 154 | metallo-sulfur cluster assembly (GO:0031163) | 2.45142881 |
| 155 | iron-sulfur cluster assembly (GO:0016226) | 2.45142881 |
| 156 | proline transport (GO:0015824) | 2.44125881 |
| 157 | neurofilament cytoskeleton organization (GO:0060052) | 2.42710987 |
| 158 | righting reflex (GO:0060013) | 2.42024287 |
| 159 | protein complex biogenesis (GO:0070271) | 2.40435862 |
| 160 | negative regulation of membrane potential (GO:0045837) | 2.37773208 |
| 161 | neuron cell-cell adhesion (GO:0007158) | 2.35823493 |
| 162 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.35043726 |
| 163 | respiratory chain complex IV assembly (GO:0008535) | 2.34768238 |
| 164 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.34727946 |
| 165 | positive regulation of TOR signaling (GO:0032008) | 2.34442174 |
| 166 | DNA damage response, detection of DNA damage (GO:0042769) | 2.33228607 |
| 167 | hydrogen ion transmembrane transport (GO:1902600) | 2.30901032 |
| 168 | glycoside metabolic process (GO:0016137) | 2.30525548 |
| 169 | transferrin transport (GO:0033572) | 2.30455708 |
| 170 | regulation of cellular respiration (GO:0043457) | 2.30369282 |
| 171 | peroxisome fission (GO:0016559) | 2.28890975 |
| 172 | cellular ketone body metabolic process (GO:0046950) | 2.28704310 |
| 173 | magnesium ion transport (GO:0015693) | 2.28337479 |
| 174 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.27959283 |
| 175 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.27697184 |
| 176 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.26977208 |
| 177 | neurotransmitter transport (GO:0006836) | 2.26910077 |
| 178 | regulation of cofactor metabolic process (GO:0051193) | 2.25455195 |
| 179 | regulation of coenzyme metabolic process (GO:0051196) | 2.25455195 |
| 180 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.25420610 |
| 181 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.22781852 |
| 182 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.22781852 |
| 183 | NADH dehydrogenase complex assembly (GO:0010257) | 2.22781852 |
| 184 | behavioral response to ethanol (GO:0048149) | 2.22499268 |
| 185 | regulation of mitochondrial fission (GO:0090140) | 2.22087442 |
| 186 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.21476393 |
| 187 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.21476393 |
| 188 | anterograde axon cargo transport (GO:0008089) | 2.20401329 |
| 189 | inositol phosphate catabolic process (GO:0071545) | 2.19258460 |
| 190 | proton transport (GO:0015992) | 2.17964220 |
| 191 | response to pheromone (GO:0019236) | 2.17484250 |
| 192 | hydrogen transport (GO:0006818) | 2.16803375 |
| 193 | de novo posttranslational protein folding (GO:0051084) | 2.16517227 |
| 194 | protein localization to mitochondrion (GO:0070585) | 2.16248053 |
| 195 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.15623370 |
| 196 | L-fucose catabolic process (GO:0042355) | 2.15139963 |
| 197 | fucose catabolic process (GO:0019317) | 2.15139963 |
| 198 | L-fucose metabolic process (GO:0042354) | 2.15139963 |
| 199 | regulation of neurotransmitter levels (GO:0001505) | 2.14721413 |
| 200 | nonmotile primary cilium assembly (GO:0035058) | 2.14380244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.77643364 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.09802002 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.03148173 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.90276680 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.81426150 |
| 6 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.79526113 |
| 7 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.41522311 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.41518484 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.15277356 |
| 10 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.15118561 |
| 11 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 3.03262918 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.94138394 |
| 13 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.86511981 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.85861257 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.78544222 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.65307234 |
| 17 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.62997571 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.58141453 |
| 19 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.57388049 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.56081927 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.50196737 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.47386621 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.45816470 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.39936577 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 2.33124921 |
| 26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.33124519 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.32180778 |
| 28 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.24894006 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.20631011 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 2.18175870 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.14089164 |
| 32 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.11294682 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.09770783 |
| 34 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.07722459 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.04961040 |
| 36 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02051938 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.01696037 |
| 38 | FUS_26573619_Chip-Seq_HEK293_Human | 2.01443061 |
| 39 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.99360218 |
| 40 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.98145548 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95043371 |
| 42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.91545150 |
| 43 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.89323100 |
| 44 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.89185193 |
| 45 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.87729672 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85884406 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78644834 |
| 48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.78400267 |
| 49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.77529963 |
| 50 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.76888605 |
| 51 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.76404726 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74924739 |
| 53 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.74678811 |
| 54 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.73182951 |
| 55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.71193714 |
| 56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.67978326 |
| 57 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.65838470 |
| 58 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.64814496 |
| 59 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.63430423 |
| 60 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.59817196 |
| 61 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.59045053 |
| 62 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59031029 |
| 63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.58062829 |
| 64 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.57063940 |
| 65 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.53763951 |
| 66 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.51696504 |
| 67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.50911767 |
| 68 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.50591145 |
| 69 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50440702 |
| 70 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.49543504 |
| 71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.49210182 |
| 72 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48508410 |
| 73 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.48304400 |
| 74 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46497261 |
| 75 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45606004 |
| 76 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.45478953 |
| 77 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.44686058 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 1.43928694 |
| 79 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.43065564 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.41073533 |
| 81 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.39734066 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37439893 |
| 83 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.36926372 |
| 84 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.36865202 |
| 85 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36280545 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36092961 |
| 87 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.35553552 |
| 88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.34646680 |
| 89 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.34596622 |
| 90 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.34179164 |
| 91 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.33994119 |
| 92 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33565277 |
| 93 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.32208415 |
| 94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32121298 |
| 95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31203985 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30658201 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30635992 |
| 98 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.29702078 |
| 99 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.29527614 |
| 100 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.29527614 |
| 101 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.28297847 |
| 102 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.27155327 |
| 103 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.25557652 |
| 104 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.25413691 |
| 105 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.25334105 |
| 106 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.24492163 |
| 107 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22095759 |
| 108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21912011 |
| 109 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.21590386 |
| 110 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.19763956 |
| 111 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.19265756 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18870504 |
| 113 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18515673 |
| 114 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.17469341 |
| 115 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.16472895 |
| 116 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.14443467 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12759686 |
| 118 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12534536 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11243545 |
| 120 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.11174727 |
| 121 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09429728 |
| 122 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.08830134 |
| 123 | JUN_21703547_ChIP-Seq_K562_Human | 1.08537061 |
| 124 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.08437365 |
| 125 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.07214342 |
| 126 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07183501 |
| 127 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05477140 |
| 128 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05342927 |
| 129 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03890768 |
| 130 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03589733 |
| 131 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.03305368 |
| 132 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02996497 |
| 133 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02881631 |
| 134 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.01393996 |
| 135 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.01107748 |
| 136 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00336171 |
| 137 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00009821 |
| 138 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99259939 |
| 139 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98575398 |
| 140 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97633601 |
| 141 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97524180 |
| 142 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.97452766 |
| 143 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.96599324 |
| 144 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96347968 |
| 145 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95654343 |
| 146 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.94348352 |
| 147 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94018516 |
| 148 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93672812 |
| 149 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.93361781 |
| 150 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92485451 |
| 151 | NCOR_22424771_ChIP-Seq_293T_Human | 0.92106471 |
| 152 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91855141 |
| 153 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.91254231 |
| 154 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90956826 |
| 155 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90273164 |
| 156 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90179489 |
| 157 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.89903376 |
| 158 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.89833420 |
| 159 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.89526344 |
| 160 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.89285627 |
| 161 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89178577 |
| 162 | AR_20517297_ChIP-Seq_VCAP_Human | 0.89069477 |
| 163 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.87948042 |
| 164 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.87936377 |
| 165 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87318209 |
| 166 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.86967051 |
| 167 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86618570 |
| 168 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.86376779 |
| 169 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85879777 |
| 170 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85785777 |
| 171 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85331719 |
| 172 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84544967 |
| 173 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84475454 |
| 174 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84303369 |
| 175 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.82584426 |
| 176 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82381038 |
| 177 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81904836 |
| 178 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.80522234 |
| 179 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80425263 |
| 180 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78366233 |
| 181 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78108199 |
| 182 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77038019 |
| 183 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76940698 |
| 184 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76420624 |
| 185 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75490183 |
| 186 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.74879856 |
| 187 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.74657191 |
| 188 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.74384243 |
| 189 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.71304532 |
| 190 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71171471 |
| 191 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.70552884 |
| 192 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67636105 |
| 193 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.67593632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.44879296 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.91505912 |
| 3 | MP0001666_abnormal_nutrient_absorption | 4.38809058 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 3.86253952 |
| 5 | MP0005365_abnormal_bile_salt | 3.35243680 |
| 6 | MP0009840_abnormal_foam_cell | 3.34543956 |
| 7 | MP0001529_abnormal_vocalization | 3.31383924 |
| 8 | MP0004043_abnormal_pH_regulation | 3.25623575 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.23009441 |
| 10 | MP0004264_abnormal_extraembryonic_tissu | 2.94656984 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.90647284 |
| 12 | MP0003880_abnormal_central_pattern | 2.77688070 |
| 13 | MP0004270_analgesia | 2.62579991 |
| 14 | MP0009046_muscle_twitch | 2.49188452 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.48178203 |
| 16 | MP0004859_abnormal_synaptic_plasticity | 2.45242086 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 2.38978314 |
| 18 | MP0000462_abnormal_digestive_system | 2.16385329 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.15081047 |
| 20 | MP0001188_hyperpigmentation | 2.13687835 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.12450623 |
| 22 | MP0009643_abnormal_urine_homeostasis | 2.09475068 |
| 23 | MP0003252_abnormal_bile_duct | 2.08729104 |
| 24 | MP0006276_abnormal_autonomic_nervous | 2.06132867 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.04382744 |
| 26 | MP0009745_abnormal_behavioral_response | 2.02969599 |
| 27 | MP0003195_calcinosis | 2.00878077 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 2.00432829 |
| 29 | MP0003283_abnormal_digestive_organ | 1.96197053 |
| 30 | MP0004147_increased_porphyrin_level | 1.93936904 |
| 31 | MP0009697_abnormal_copulation | 1.93860006 |
| 32 | MP0005377_hearing/vestibular/ear_phenot | 1.93004284 |
| 33 | MP0003878_abnormal_ear_physiology | 1.93004284 |
| 34 | MP0002064_seizures | 1.91752003 |
| 35 | MP0003866_abnormal_defecation | 1.89566386 |
| 36 | MP0003635_abnormal_synaptic_transmissio | 1.88033735 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.87246658 |
| 38 | MP0003122_maternal_imprinting | 1.80921166 |
| 39 | MP0005332_abnormal_amino_acid | 1.79970247 |
| 40 | MP0002272_abnormal_nervous_system | 1.77419644 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.74988689 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 1.68772408 |
| 43 | MP0003787_abnormal_imprinting | 1.67071309 |
| 44 | MP0002693_abnormal_pancreas_physiology | 1.65398496 |
| 45 | MP0008789_abnormal_olfactory_epithelium | 1.61867970 |
| 46 | MP0002063_abnormal_learning/memory/cond | 1.60004424 |
| 47 | MP0001905_abnormal_dopamine_level | 1.58975379 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.58541931 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.57227064 |
| 50 | MP0001765_abnormal_ion_homeostasis | 1.53703066 |
| 51 | MP0001944_abnormal_pancreas_morphology | 1.51994019 |
| 52 | MP0001664_abnormal_digestion | 1.49454812 |
| 53 | MP0010386_abnormal_urinary_bladder | 1.49320839 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 1.47679038 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 1.46194326 |
| 56 | MP0002909_abnormal_adrenal_gland | 1.43253013 |
| 57 | MP0000678_abnormal_parathyroid_gland | 1.42858249 |
| 58 | MP0005379_endocrine/exocrine_gland_phen | 1.42529421 |
| 59 | MP0004924_abnormal_behavior | 1.42273766 |
| 60 | MP0005386_behavior/neurological_phenoty | 1.42273766 |
| 61 | MP0003868_abnormal_feces_composition | 1.41865489 |
| 62 | MP0001486_abnormal_startle_reflex | 1.41184357 |
| 63 | MP0002734_abnormal_mechanical_nocicepti | 1.41108585 |
| 64 | MP0001756_abnormal_urination | 1.40182991 |
| 65 | MP0005499_abnormal_olfactory_system | 1.39651783 |
| 66 | MP0005394_taste/olfaction_phenotype | 1.39651783 |
| 67 | MP0002118_abnormal_lipid_homeostasis | 1.39581789 |
| 68 | MP0005381_digestive/alimentary_phenotyp | 1.36695627 |
| 69 | MP0002234_abnormal_pharynx_morphology | 1.36690690 |
| 70 | MP0001873_stomach_inflammation | 1.35520746 |
| 71 | MP0002822_catalepsy | 1.35253333 |
| 72 | MP0002876_abnormal_thyroid_physiology | 1.34465599 |
| 73 | MP0002102_abnormal_ear_morphology | 1.34465305 |
| 74 | MP0004215_abnormal_myocardial_fiber | 1.33077198 |
| 75 | MP0000013_abnormal_adipose_tissue | 1.32231795 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 1.30686421 |
| 77 | MP0003121_genomic_imprinting | 1.30590232 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 1.30584382 |
| 79 | MP0004142_abnormal_muscle_tone | 1.30536130 |
| 80 | MP0005310_abnormal_salivary_gland | 1.29758596 |
| 81 | MP0005083_abnormal_biliary_tract | 1.29169711 |
| 82 | MP0003186_abnormal_redox_activity | 1.29058393 |
| 83 | MP0001663_abnormal_digestive_system | 1.28978596 |
| 84 | MP0000609_abnormal_liver_physiology | 1.28773461 |
| 85 | MP0005423_abnormal_somatic_nervous | 1.28367977 |
| 86 | MP0001968_abnormal_touch/_nociception | 1.27895217 |
| 87 | MP0002557_abnormal_social/conspecific_i | 1.27561720 |
| 88 | MP0000778_abnormal_nervous_system | 1.26897087 |
| 89 | MP0006054_spinal_hemorrhage | 1.25336472 |
| 90 | MP0000538_abnormal_urinary_bladder | 1.25327064 |
| 91 | MP0005646_abnormal_pituitary_gland | 1.25088236 |
| 92 | MP0003300_gastrointestinal_ulcer | 1.21982968 |
| 93 | MP0001502_abnormal_circadian_rhythm | 1.21326017 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 1.20183649 |
| 95 | MP0001984_abnormal_olfaction | 1.19765840 |
| 96 | MP0005187_abnormal_penis_morphology | 1.17588929 |
| 97 | MP0000613_abnormal_salivary_gland | 1.17197042 |
| 98 | MP0004811_abnormal_neuron_physiology | 1.16821709 |
| 99 | MP0003567_abnormal_fetal_cardiomyocyte | 1.11576787 |
| 100 | MP0000490_abnormal_crypts_of | 1.10523511 |
| 101 | MP0002733_abnormal_thermal_nociception | 1.09844935 |
| 102 | MP0002837_dystrophic_cardiac_calcinosis | 1.08800453 |
| 103 | MP0010155_abnormal_intestine_physiology | 1.08536698 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 1.07542945 |
| 105 | MP0005248_abnormal_Harderian_gland | 1.06596808 |
| 106 | MP0001970_abnormal_pain_threshold | 1.06575547 |
| 107 | MP0002736_abnormal_nociception_after | 1.05609994 |
| 108 | MP0008877_abnormal_DNA_methylation | 1.04871481 |
| 109 | MP0001501_abnormal_sleep_pattern | 1.04709558 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 1.03254578 |
| 111 | MP0003656_abnormal_erythrocyte_physiolo | 1.03087937 |
| 112 | MP0002163_abnormal_gland_morphology | 1.02975378 |
| 113 | MP0000477_abnormal_intestine_morphology | 1.02717769 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 1.02033349 |
| 115 | MP0002735_abnormal_chemical_nociception | 1.01371311 |
| 116 | MP0000631_abnormal_neuroendocrine_gland | 1.01211363 |
| 117 | MP0002067_abnormal_sensory_capabilities | 0.98538140 |
| 118 | MP0002160_abnormal_reproductive_system | 0.97731657 |
| 119 | MP0010352_gastrointestinal_tract_polyps | 0.96659288 |
| 120 | MP0008004_abnormal_stomach_pH | 0.96633272 |
| 121 | MP0002229_neurodegeneration | 0.95339454 |
| 122 | MP0004885_abnormal_endolymph | 0.93952161 |
| 123 | MP0003221_abnormal_cardiomyocyte_apopto | 0.93083683 |
| 124 | MP0002066_abnormal_motor_capabilities/c | 0.92062891 |
| 125 | MP0003633_abnormal_nervous_system | 0.91850291 |
| 126 | MP0008058_abnormal_DNA_repair | 0.90754942 |
| 127 | MP0005058_abnormal_lysosome_morphology | 0.89449804 |
| 128 | MP0008872_abnormal_physiological_respon | 0.88652760 |
| 129 | MP0005448_abnormal_energy_balance | 0.88038984 |
| 130 | MP0006072_abnormal_retinal_apoptosis | 0.87953064 |
| 131 | MP0003953_abnormal_hormone_level | 0.87390588 |
| 132 | MP0002882_abnormal_neuron_morphology | 0.87240434 |
| 133 | MP0001440_abnormal_grooming_behavior | 0.86973991 |
| 134 | MP0000681_abnormal_thyroid_gland | 0.86819674 |
| 135 | MP0003631_nervous_system_phenotype | 0.86552511 |
| 136 | MP0002638_abnormal_pupillary_reflex | 0.85806779 |
| 137 | MP0002090_abnormal_vision | 0.84624746 |
| 138 | MP0002184_abnormal_innervation | 0.84570934 |
| 139 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83639122 |
| 140 | MP0008260_abnormal_autophagy | 0.82865409 |
| 141 | MP0005253_abnormal_eye_physiology | 0.82578168 |
| 142 | MP0000358_abnormal_cell_content/ | 0.82433392 |
| 143 | MP0000955_abnormal_spinal_cord | 0.82247936 |
| 144 | MP0008775_abnormal_heart_ventricle | 0.81530526 |
| 145 | MP0004133_heterotaxia | 0.79424936 |
| 146 | MP0002136_abnormal_kidney_physiology | 0.79109169 |
| 147 | MP0009642_abnormal_blood_homeostasis | 0.79094354 |
| 148 | MP0004085_abnormal_heartbeat | 0.77842012 |
| 149 | MP0004484_altered_response_of | 0.77101037 |
| 150 | MP0000003_abnormal_adipose_tissue | 0.75602971 |
| 151 | MP0002009_preneoplasia | 0.72694472 |
| 152 | MP0002069_abnormal_eating/drinking_beha | 0.71103029 |
| 153 | MP0002896_abnormal_bone_mineralization | 0.71082029 |
| 154 | MP0005167_abnormal_blood-brain_barrier | 0.70400643 |
| 155 | MP0002152_abnormal_brain_morphology | 0.69209868 |
| 156 | MP0000015_abnormal_ear_pigmentation | 0.69135428 |
| 157 | MP0005408_hypopigmentation | 0.66581599 |
| 158 | MP0001764_abnormal_homeostasis | 0.66202054 |
| 159 | MP0000230_abnormal_systemic_arterial | 0.66129430 |
| 160 | MP0001346_abnormal_lacrimal_gland | 0.65321761 |
| 161 | MP0003879_abnormal_hair_cell | 0.63498699 |
| 162 | MP0002277_abnormal_respiratory_mucosa | 0.62426106 |
| 163 | MP0005266_abnormal_metabolism | 0.62388048 |
| 164 | MP0005535_abnormal_body_temperature | 0.59699065 |
| 165 | MP0009384_cardiac_valve_regurgitation | 0.57197889 |
| 166 | MP0000598_abnormal_liver_morphology | 0.56759556 |
| 167 | MP0000537_abnormal_urethra_morphology | 0.55611984 |
| 168 | MP0003718_maternal_effect | 0.53725819 |
| 169 | MP0000470_abnormal_stomach_morphology | 0.53415213 |
| 170 | MP0002098_abnormal_vibrissa_morphology | 0.52712021 |
| 171 | MP0001881_abnormal_mammary_gland | 0.51684438 |
| 172 | MP0005334_abnormal_fat_pad | 0.49527071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.82762644 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 4.23699665 |
| 3 | Gout (HP:0001997) | 4.17534348 |
| 4 | Ileus (HP:0002595) | 3.99093116 |
| 5 | Hyperglycinuria (HP:0003108) | 3.96538477 |
| 6 | Limb dystonia (HP:0002451) | 3.91693141 |
| 7 | Ketoacidosis (HP:0001993) | 3.84744703 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.76172677 |
| 9 | Hypoglycemic seizures (HP:0002173) | 3.75903759 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 3.70822060 |
| 11 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.70350078 |
| 12 | Symptomatic seizures (HP:0011145) | 3.57117370 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.36660234 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.26020774 |
| 15 | Abnormality of purine metabolism (HP:0004352) | 3.24612048 |
| 16 | Generalized aminoaciduria (HP:0002909) | 3.23204412 |
| 17 | Abnormality of chloride homeostasis (HP:0011422) | 3.22977316 |
| 18 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.19566389 |
| 19 | Abnormality of urine glucose concentration (HP:0011016) | 3.19367546 |
| 20 | Glycosuria (HP:0003076) | 3.19367546 |
| 21 | Late onset (HP:0003584) | 3.10805742 |
| 22 | Progressive macrocephaly (HP:0004481) | 3.04614653 |
| 23 | Acute encephalopathy (HP:0006846) | 3.03436877 |
| 24 | Hydroxyprolinuria (HP:0003080) | 3.00253466 |
| 25 | Abnormality of proline metabolism (HP:0010907) | 3.00253466 |
| 26 | Abdominal distention (HP:0003270) | 2.99794247 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.98856659 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 2.98856659 |
| 29 | Right ventricular cardiomyopathy (HP:0011663) | 2.97371975 |
| 30 | Abnormal pancreas size (HP:0012094) | 2.96708532 |
| 31 | Hyperglycemia (HP:0003074) | 2.93341276 |
| 32 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.92011295 |
| 33 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.92011295 |
| 34 | Palpitations (HP:0001962) | 2.90026755 |
| 35 | Gait imbalance (HP:0002141) | 2.89542661 |
| 36 | Decreased circulating renin level (HP:0003351) | 2.84945889 |
| 37 | Ketosis (HP:0001946) | 2.83649937 |
| 38 | Medial flaring of the eyebrow (HP:0010747) | 2.82135172 |
| 39 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.79483427 |
| 40 | Abnormality of alanine metabolism (HP:0010916) | 2.79483427 |
| 41 | Hyperalaninemia (HP:0003348) | 2.79483427 |
| 42 | Increased CSF lactate (HP:0002490) | 2.77082036 |
| 43 | Abnormality of renin-angiotensin system (HP:0000847) | 2.76443962 |
| 44 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.76052431 |
| 45 | Fat malabsorption (HP:0002630) | 2.75055569 |
| 46 | Hypobetalipoproteinemia (HP:0003563) | 2.73665646 |
| 47 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.73038888 |
| 48 | Acanthocytosis (HP:0001927) | 2.72588201 |
| 49 | Mitochondrial inheritance (HP:0001427) | 2.69312649 |
| 50 | Abnormal tarsal ossification (HP:0008369) | 2.66628455 |
| 51 | Cerebral edema (HP:0002181) | 2.61465369 |
| 52 | Hepatocellular necrosis (HP:0001404) | 2.60269835 |
| 53 | Hypokalemia (HP:0002900) | 2.60225229 |
| 54 | Increased purine levels (HP:0004368) | 2.60040119 |
| 55 | Hyperuricemia (HP:0002149) | 2.60040119 |
| 56 | Proximal tubulopathy (HP:0000114) | 2.59746715 |
| 57 | Hyperphosphaturia (HP:0003109) | 2.59703782 |
| 58 | Congenital primary aphakia (HP:0007707) | 2.57650566 |
| 59 | Polycythemia (HP:0001901) | 2.56861899 |
| 60 | Increased hepatocellular lipid droplets (HP:0006565) | 2.55462216 |
| 61 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.54356494 |
| 62 | Focal motor seizures (HP:0011153) | 2.54093367 |
| 63 | Dicarboxylic aciduria (HP:0003215) | 2.53287533 |
| 64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53287533 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.53097518 |
| 66 | Polyphagia (HP:0002591) | 2.51448845 |
| 67 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.49709612 |
| 68 | Hyperaldosteronism (HP:0000859) | 2.49332911 |
| 69 | Nephrogenic diabetes insipidus (HP:0009806) | 2.48316771 |
| 70 | Hyperparathyroidism (HP:0000843) | 2.47503666 |
| 71 | Xanthomatosis (HP:0000991) | 2.46993984 |
| 72 | Hyperglycinemia (HP:0002154) | 2.46083925 |
| 73 | Lipid accumulation in hepatocytes (HP:0006561) | 2.45878992 |
| 74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.44352807 |
| 75 | Mucopolysacchariduria (HP:0008155) | 2.44352807 |
| 76 | Myokymia (HP:0002411) | 2.43488634 |
| 77 | Muscular hypotonia of the trunk (HP:0008936) | 2.42080317 |
| 78 | Malnutrition (HP:0004395) | 2.41730493 |
| 79 | Abnormal biliary tract morphology (HP:0012440) | 2.41294233 |
| 80 | Metabolic acidosis (HP:0001942) | 2.40786248 |
| 81 | Hypsarrhythmia (HP:0002521) | 2.38683315 |
| 82 | Intrahepatic cholestasis (HP:0001406) | 2.38280523 |
| 83 | Hyperammonemia (HP:0001987) | 2.38264180 |
| 84 | EEG with generalized epileptiform discharges (HP:0011198) | 2.35361823 |
| 85 | Hepatic necrosis (HP:0002605) | 2.34213049 |
| 86 | Epileptiform EEG discharges (HP:0011182) | 2.32219785 |
| 87 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.31854665 |
| 88 | Lactic acidosis (HP:0003128) | 2.29387903 |
| 89 | Cupped ribs (HP:0000887) | 2.29118612 |
| 90 | Increased serum pyruvate (HP:0003542) | 2.25299995 |
| 91 | Poor suck (HP:0002033) | 2.24392084 |
| 92 | Flat acetabular roof (HP:0003180) | 2.23952380 |
| 93 | Pheochromocytoma (HP:0002666) | 2.23812700 |
| 94 | Exocrine pancreatic insufficiency (HP:0001738) | 2.23767098 |
| 95 | Increased serum lactate (HP:0002151) | 2.22915801 |
| 96 | Lethargy (HP:0001254) | 2.22277344 |
| 97 | Metabolic alkalosis (HP:0200114) | 2.21558965 |
| 98 | Epileptic encephalopathy (HP:0200134) | 2.20367382 |
| 99 | 3-Methylglutaconic aciduria (HP:0003535) | 2.19955327 |
| 100 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.19166105 |
| 101 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.19166105 |
| 102 | Febrile seizures (HP:0002373) | 2.18452603 |
| 103 | Goiter (HP:0000853) | 2.16977777 |
| 104 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.16966304 |
| 105 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.16966304 |
| 106 | Neuroendocrine neoplasm (HP:0100634) | 2.15946276 |
| 107 | Hypolipoproteinemia (HP:0010981) | 2.15717628 |
| 108 | Insulin resistance (HP:0000855) | 2.14957744 |
| 109 | Pancreatic fibrosis (HP:0100732) | 2.14698261 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14597181 |
| 111 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14597181 |
| 112 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14597181 |
| 113 | Type II lissencephaly (HP:0007260) | 2.13930093 |
| 114 | Increased intramyocellular lipid droplets (HP:0012240) | 2.11770853 |
| 115 | Abnormality of nucleobase metabolism (HP:0010932) | 2.10340758 |
| 116 | Drooling (HP:0002307) | 2.10206060 |
| 117 | Pancreatic cysts (HP:0001737) | 2.10017712 |
| 118 | Abnormality of potassium homeostasis (HP:0011042) | 2.09860111 |
| 119 | Abnormality of magnesium homeostasis (HP:0004921) | 2.08326278 |
| 120 | Hyperventilation (HP:0002883) | 2.07915745 |
| 121 | Alkalosis (HP:0001948) | 2.07868026 |
| 122 | Myopathic facies (HP:0002058) | 2.06765986 |
| 123 | Dehydration (HP:0001944) | 2.05289135 |
| 124 | Hypothermia (HP:0002045) | 2.05228977 |
| 125 | Abnormality of glycolysis (HP:0004366) | 2.04772459 |
| 126 | Hypotension (HP:0002615) | 2.04244344 |
| 127 | Generalized tonic-clonic seizures (HP:0002069) | 2.04051914 |
| 128 | Poikilocytosis (HP:0004447) | 2.01951203 |
| 129 | Increased muscle lipid content (HP:0009058) | 2.01534099 |
| 130 | Abnormality of the intrinsic pathway (HP:0010989) | 2.01109191 |
| 131 | Sensorimotor neuropathy (HP:0007141) | 2.00970541 |
| 132 | Irritability (HP:0000737) | 2.00837630 |
| 133 | Abnormal urine phosphate concentration (HP:0012599) | 1.99857735 |
| 134 | Dysostosis multiplex (HP:0000943) | 1.99476133 |
| 135 | Pancreatitis (HP:0001733) | 1.99134384 |
| 136 | Syncope (HP:0001279) | 1.98346824 |
| 137 | Vacuolated lymphocytes (HP:0001922) | 1.97890842 |
| 138 | Abnormality of macular pigmentation (HP:0008002) | 1.97782702 |
| 139 | Urinary urgency (HP:0000012) | 1.97614878 |
| 140 | Spastic tetraplegia (HP:0002510) | 1.97447813 |
| 141 | Renal cortical cysts (HP:0000803) | 1.97132927 |
| 142 | Focal seizures (HP:0007359) | 1.96772283 |
| 143 | Hyperbilirubinemia (HP:0002904) | 1.96425975 |
| 144 | Chronic bronchitis (HP:0004469) | 1.96092477 |
| 145 | Adrenal overactivity (HP:0002717) | 1.95739293 |
| 146 | Short tibia (HP:0005736) | 1.95698925 |
| 147 | Hypokalemic alkalosis (HP:0001949) | 1.95301000 |
| 148 | Abnormality of the corticospinal tract (HP:0002492) | 1.94834452 |
| 149 | Nephrolithiasis (HP:0000787) | 1.92591597 |
| 150 | Methylmalonic acidemia (HP:0002912) | 1.92492816 |
| 151 | Hyperphosphatemia (HP:0002905) | 1.92042133 |
| 152 | Amyotrophic lateral sclerosis (HP:0007354) | 1.90876062 |
| 153 | Cerebral hypomyelination (HP:0006808) | 1.89632998 |
| 154 | Absence seizures (HP:0002121) | 1.89399750 |
| 155 | Abnormal cartilage morphology (HP:0002763) | 1.89212726 |
| 156 | True hermaphroditism (HP:0010459) | 1.89179150 |
| 157 | Abnormality of vitamin B metabolism (HP:0004340) | 1.88565438 |
| 158 | Specific learning disability (HP:0001328) | 1.87614185 |
| 159 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.86094597 |
| 160 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.85449967 |
| 161 | Genital tract atresia (HP:0001827) | 1.85425932 |
| 162 | CNS demyelination (HP:0007305) | 1.84485813 |
| 163 | Lissencephaly (HP:0001339) | 1.83247974 |
| 164 | Emotional lability (HP:0000712) | 1.82891942 |
| 165 | Villous atrophy (HP:0011473) | 1.82764284 |
| 166 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.82764284 |
| 167 | Dialeptic seizures (HP:0011146) | 1.81697882 |
| 168 | Vaginal atresia (HP:0000148) | 1.81158167 |
| 169 | Atonic seizures (HP:0010819) | 1.80279285 |
| 170 | CNS hypomyelination (HP:0003429) | 1.79208323 |
| 171 | Degeneration of anterior horn cells (HP:0002398) | 1.78785686 |
| 172 | Abnormality of the anterior horn cell (HP:0006802) | 1.78785686 |
| 173 | Progressive microcephaly (HP:0000253) | 1.78662994 |
| 174 | Excessive salivation (HP:0003781) | 1.78609410 |
| 175 | Delayed myelination (HP:0012448) | 1.77209779 |
| 176 | Molar tooth sign on MRI (HP:0002419) | 1.76484487 |
| 177 | Abnormality of midbrain morphology (HP:0002418) | 1.76484487 |
| 178 | Abnormality of serum amino acid levels (HP:0003112) | 1.74355902 |
| 179 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.74176851 |
| 180 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.73771300 |
| 181 | Status epilepticus (HP:0002133) | 1.73097385 |
| 182 | Inability to walk (HP:0002540) | 1.70979139 |
| 183 | Respiratory failure (HP:0002878) | 1.70749817 |
| 184 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.70150574 |
| 185 | Methylmalonic aciduria (HP:0012120) | 1.68359090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.37228634 |
| 2 | INSRR | 3.59116387 |
| 3 | MAPK15 | 3.56667297 |
| 4 | MST4 | 3.19146311 |
| 5 | MST1R | 2.94119445 |
| 6 | EPHA2 | 2.84805105 |
| 7 | MAP3K4 | 2.69448570 |
| 8 | MARK1 | 2.67030590 |
| 9 | BCKDK | 2.56174748 |
| 10 | MAP2K2 | 2.54587118 |
| 11 | ARAF | 2.53896996 |
| 12 | MAP2K7 | 2.51026480 |
| 13 | LMTK2 | 2.50457165 |
| 14 | MAP3K2 | 2.46776248 |
| 15 | MAP4K2 | 2.26752788 |
| 16 | STK39 | 2.06888103 |
| 17 | SIK3 | 2.03501064 |
| 18 | TESK1 | 2.02809451 |
| 19 | EIF2AK3 | 1.99331423 |
| 20 | CSNK1G3 | 1.97085544 |
| 21 | EIF2AK1 | 1.96179784 |
| 22 | CSNK1G2 | 1.93212030 |
| 23 | NTRK1 | 1.89921083 |
| 24 | CASK | 1.84421445 |
| 25 | ERN1 | 1.82390171 |
| 26 | BMPR1B | 1.78909597 |
| 27 | TRIM28 | 1.77041410 |
| 28 | NTRK3 | 1.74466471 |
| 29 | EPHA4 | 1.73355122 |
| 30 | TAOK3 | 1.68363491 |
| 31 | PIM2 | 1.67513691 |
| 32 | CSNK1G1 | 1.65696234 |
| 33 | CSNK1A1L | 1.61920728 |
| 34 | PRKG2 | 1.59801385 |
| 35 | PASK | 1.56232127 |
| 36 | WNK4 | 1.51875655 |
| 37 | NME1 | 1.51618702 |
| 38 | OXSR1 | 1.47561727 |
| 39 | FER | 1.46380470 |
| 40 | SCYL2 | 1.45497019 |
| 41 | TNIK | 1.39468232 |
| 42 | PHKG2 | 1.38266689 |
| 43 | PHKG1 | 1.38266689 |
| 44 | CCNB1 | 1.37220088 |
| 45 | GRK1 | 1.35100516 |
| 46 | BCR | 1.33273694 |
| 47 | MET | 1.32943792 |
| 48 | MAP2K1 | 1.31006717 |
| 49 | RPS6KA4 | 1.29005369 |
| 50 | EPHB2 | 1.24297350 |
| 51 | IRAK3 | 1.23864917 |
| 52 | SRPK1 | 1.23696617 |
| 53 | PTK6 | 1.23584018 |
| 54 | BUB1 | 1.19900192 |
| 55 | MAP3K1 | 1.19435274 |
| 56 | MAPK13 | 1.18615356 |
| 57 | AKT3 | 1.16089420 |
| 58 | PRKCI | 1.12515559 |
| 59 | MINK1 | 1.11793197 |
| 60 | CDK19 | 1.10922717 |
| 61 | MAPKAPK3 | 1.10311238 |
| 62 | MAP3K3 | 1.10263821 |
| 63 | PLK2 | 1.07611433 |
| 64 | MAP2K4 | 1.05354412 |
| 65 | GRK6 | 1.03478044 |
| 66 | MAP3K11 | 1.02622110 |
| 67 | BRAF | 1.01256472 |
| 68 | NEK9 | 1.00038669 |
| 69 | NLK | 0.99816082 |
| 70 | PTK2 | 0.97796420 |
| 71 | FLT3 | 0.97444537 |
| 72 | LIMK1 | 0.96244104 |
| 73 | DYRK2 | 0.95660845 |
| 74 | MAP3K12 | 0.95473094 |
| 75 | PIK3CA | 0.94419650 |
| 76 | DAPK2 | 0.93536053 |
| 77 | HIPK2 | 0.91551155 |
| 78 | PRKCG | 0.90034912 |
| 79 | CAMKK2 | 0.87625692 |
| 80 | SIK1 | 0.87086223 |
| 81 | EPHA3 | 0.86815134 |
| 82 | KSR2 | 0.86207376 |
| 83 | CAMK2A | 0.83176661 |
| 84 | PAK6 | 0.82683367 |
| 85 | PAK3 | 0.82676954 |
| 86 | EPHB1 | 0.81924680 |
| 87 | IRAK1 | 0.81281474 |
| 88 | PBK | 0.80898659 |
| 89 | CAMK2B | 0.80692489 |
| 90 | TRIB3 | 0.79826488 |
| 91 | MAP2K6 | 0.78537619 |
| 92 | ERBB3 | 0.75375790 |
| 93 | KSR1 | 0.75197900 |
| 94 | PRKD3 | 0.73245288 |
| 95 | MATK | 0.72021409 |
| 96 | ACVR1B | 0.71961996 |
| 97 | ABL2 | 0.70474743 |
| 98 | STK16 | 0.69208671 |
| 99 | LATS2 | 0.68923620 |
| 100 | WNK3 | 0.67379110 |
| 101 | CDK14 | 0.66533231 |
| 102 | MYLK | 0.64716901 |
| 103 | PRKAA1 | 0.63358345 |
| 104 | BRSK2 | 0.62706060 |
| 105 | ZAK | 0.61661268 |
| 106 | CAMK2D | 0.60799175 |
| 107 | TAOK1 | 0.59617420 |
| 108 | DYRK3 | 0.58110752 |
| 109 | PLK1 | 0.57689296 |
| 110 | ADRBK2 | 0.57070355 |
| 111 | PIK3CG | 0.56720302 |
| 112 | RPS6KA5 | 0.56450911 |
| 113 | RIPK1 | 0.56132652 |
| 114 | TIE1 | 0.55972737 |
| 115 | STK24 | 0.55948058 |
| 116 | TSSK6 | 0.55314342 |
| 117 | TBK1 | 0.55179741 |
| 118 | PDK4 | 0.55152128 |
| 119 | PDK3 | 0.55152128 |
| 120 | NEK1 | 0.55074947 |
| 121 | NTRK2 | 0.54451083 |
| 122 | DAPK1 | 0.52722376 |
| 123 | PLK3 | 0.52162248 |
| 124 | CHUK | 0.51500987 |
| 125 | ERBB4 | 0.50112072 |
| 126 | MAPKAPK5 | 0.49237586 |
| 127 | CDK5 | 0.49107530 |
| 128 | NUAK1 | 0.48799670 |
| 129 | CSNK1E | 0.48123329 |
| 130 | DYRK1B | 0.47608999 |
| 131 | CAMK2G | 0.46729625 |
| 132 | ERBB2 | 0.46435550 |
| 133 | PAK4 | 0.46028083 |
| 134 | NME2 | 0.45506146 |
| 135 | DYRK1A | 0.45253336 |
| 136 | ZAP70 | 0.45198685 |
| 137 | CDK18 | 0.44193683 |
| 138 | BMPR2 | 0.42883401 |
| 139 | MAP3K10 | 0.42346796 |
| 140 | PRKAA2 | 0.41366275 |
| 141 | TGFBR2 | 0.40135088 |
| 142 | MAP3K5 | 0.39035997 |
| 143 | TLK1 | 0.38730642 |
| 144 | CDK8 | 0.37622491 |
| 145 | STK38L | 0.37376466 |
| 146 | CDK15 | 0.36924647 |
| 147 | PRKCE | 0.36639928 |
| 148 | PINK1 | 0.35893866 |
| 149 | MAPKAPK2 | 0.35539639 |
| 150 | MAP2K3 | 0.35496407 |
| 151 | CDK11A | 0.35099009 |
| 152 | JAK3 | 0.34902718 |
| 153 | LRRK2 | 0.34618290 |
| 154 | PDK2 | 0.34456132 |
| 155 | PRKACB | 0.33833260 |
| 156 | CSNK2A1 | 0.33386887 |
| 157 | PRKACA | 0.32423736 |
| 158 | PDPK1 | 0.31452713 |
| 159 | MAPK11 | 0.30631221 |
| 160 | CSNK1A1 | 0.29982734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.89275716 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.49213477 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.30887527 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.75947704 |
| 5 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.74021899 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 2.62206288 |
| 7 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.34936201 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.33354719 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.27856737 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.23591577 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.21720684 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.11586191 |
| 13 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.10421135 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 2.02169690 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.01320039 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.96670212 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88545150 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.87416000 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.84956713 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.84410185 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.82147444 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.80555113 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.74967598 |
| 24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.69531156 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67941216 |
| 26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.59115279 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.56063432 |
| 28 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.53025895 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47740566 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44554114 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.41979116 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.41178317 |
| 33 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.38735197 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.37382582 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.36226197 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.33456817 |
| 37 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.27999268 |
| 38 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.24951557 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.20752689 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.20712501 |
| 41 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.17854174 |
| 42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16452719 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15843354 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13463649 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.11548150 |
| 46 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.10744293 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.08742150 |
| 48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.08540276 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.08506294 |
| 50 | Morphine addiction_Homo sapiens_hsa05032 | 1.07651357 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06973995 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04761533 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.04563556 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03499550 |
| 55 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.00192153 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99339802 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98054635 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.97360294 |
| 59 | Cocaine addiction_Homo sapiens_hsa05030 | 0.93660706 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93502778 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93165309 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.92631894 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91448569 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.89182671 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89091781 |
| 66 | RNA polymerase_Homo sapiens_hsa03020 | 0.88659665 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.88603429 |
| 68 | Taste transduction_Homo sapiens_hsa04742 | 0.88579233 |
| 69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.83937845 |
| 70 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.82411814 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.82177610 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81856826 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.81436616 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80638070 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80182517 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79925219 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79202143 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79168909 |
| 79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.78672472 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.78478443 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77725544 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76756120 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74461527 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.74342973 |
| 85 | Circadian entrainment_Homo sapiens_hsa04713 | 0.73396372 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73115148 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71861476 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71753375 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71680180 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70619600 |
| 91 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.70065850 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.69822188 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68925297 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67936519 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65996765 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65996499 |
| 97 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64504953 |
| 98 | RNA degradation_Homo sapiens_hsa03018 | 0.64118704 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61372661 |
| 100 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.58779647 |
| 101 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57259179 |
| 102 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.57107822 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56247796 |
| 104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54888291 |
| 105 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54475535 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53517905 |
| 107 | Ribosome_Homo sapiens_hsa03010 | 0.53215626 |
| 108 | Lysosome_Homo sapiens_hsa04142 | 0.53004169 |
| 109 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52567162 |
| 110 | Parkinsons disease_Homo sapiens_hsa05012 | 0.51770389 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.51301458 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50856870 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.49671231 |
| 114 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49613620 |
| 115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.48962797 |
| 116 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.48854619 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47806712 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45792080 |
| 119 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44280254 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43907312 |
| 121 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43356060 |
| 122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42690646 |
| 123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41456450 |
| 124 | Alzheimers disease_Homo sapiens_hsa05010 | 0.41227413 |
| 125 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38800704 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36637356 |
| 127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30143750 |
| 128 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.29637017 |
| 129 | Proteasome_Homo sapiens_hsa03050 | 0.29394203 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.28491933 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26667538 |
| 132 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.26466546 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23494803 |
| 134 | Hepatitis C_Homo sapiens_hsa05160 | 0.23244143 |
| 135 | Huntingtons disease_Homo sapiens_hsa05016 | 0.18533649 |
| 136 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.18099978 |

